Adage Capital Partners’s Sangamo Therapeutics SGMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-950,000	Closed	-$10.9M	–	732
2018 Q4	$10.9M	Sell	950,000 -450,000	-32%	-$5.17M	0.03%	493
2018 Q3	$23.7M	Sell	1,400,000 -1,850,000	-57%	-$31.4M	0.05%	364
2018 Q2	$46.2M	Buy	3,250,000 +950,000	+41%	+$13.5M	0.11%	238
2018 Q1	$43.7M	Sell	2,300,000 -100,000	-4%	-$1.9M	0.1%	249
2017 Q4	$39.4M	Sell	2,400,000 -800,000	-25%	-$13.1M	0.09%	271
2017 Q3	$48M	Sell	3,200,000 -800,000	-20%	-$12M	0.12%	229
2017 Q2	$35.2M	Buy	4,000,000 +1,000,000	+33%	+$8.8M	0.09%	304
2017 Q1	$15.6M	Buy	3,000,000 +500,000	+20%	+$2.6M	0.04%	451
2016 Q4	$7.63M	Hold	2,500,000	–	–	0.02%	564
2016 Q3	$11.6M	Hold	2,500,000	–	–	0.03%	495
2016 Q2	$14.5M	Buy	2,500,000 +650,000	+35%	+$3.76M	0.04%	440
2016 Q1	$11.2M	Buy	1,850,000 +950,000	+106%	+$5.75M	0.03%	496
2015 Q4	$8.22M	Hold	900,000	–	–	0.02%	551
2015 Q3	$5.08M	Sell	900,000 -450,000	-33%	-$2.54M	0.01%	613
2015 Q2	$15M	Buy	1,350,000 +50,000	+4%	+$555K	0.04%	475
2015 Q1	$20.4M	Sell	1,300,000 -1,000,000	-43%	-$15.7M	0.05%	415
2014 Q4	$35M	Sell	2,300,000 -250,000	-10%	-$3.8M	0.09%	290
2014 Q3	$27.5M	Hold	2,550,000	–	–	0.07%	324
2014 Q2	$38.9M	Sell	2,550,000 -250,000	-9%	-$3.82M	0.1%	255
2014 Q1	$50.6M	Sell	2,800,000 -750,000	-21%	-$13.6M	0.14%	197
2013 Q4	$49.3M	Sell	3,550,000 -177,800	-5%	-$2.47M	0.13%	216
2013 Q3	$39.1M	Buy	3,727,800 +2,327,800	+166%	+$24.4M	0.11%	237
2013 Q2	$10.9M	Buy	+1,400,000	New	+$10.9M	0.03%	481